Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -89.24%-3.48M | -27.15%-865.7K | -0.80%-456.92K | 32.91%-3.55M | 55.41%-578.08K | 34.69%-1.84M | -27.75%-680.87K | 30.06%-453.29K | -994.67%-5.3M | -1,116.76%-1.3M |
| Net income from continuing operations | -149.09%-3.69M | -22.19%-990.97K | 16.52%-352.78K | 34.66%-3.17M | 45.00%-453.73K | 39.94%-1.48M | -60.54%-810.98K | 59.86%-422.6K | -188.91%-4.85M | -405.07%-825.03K |
| Depreciation and amortization | 118.65%14.92K | 85.32%11.75K | 113.37%11.63K | 84.85%26.74K | 52.08%8.12K | 26.46%6.83K | 75.36%6.34K | 4,766.96%5.45K | --14.46K | --5.34K |
| Asset impairment expenditure | ---- | ---- | ---- | -82.54%15.46K | ---- | ---- | ---- | ---- | 342.76%88.56K | ---- |
| Remuneration paid in stock | --0 | --394.35K | --0 | -98.30%13.69K | --0 | --0 | --0 | -98.30%13.69K | --806.32K | --0 |
| Deferred tax | -57.42%-788.67K | ---- | ---- | ---- | ---- | 37.45%-500.99K | 61.16%-64.14K | 48.59%-15.35K | ---- | ---- |
| Other non cashItems | ---- | 47.41%-33.73K | 16.42%-12.83K | 41.13%-611.43K | ---- | ---- | ---64.14K | ---15.35K | -181.66%-1.04M | ---- |
| Change In working capital | 628.82%979.31K | -231.49%-247.1K | -198.61%-102.95K | 153.70%170.82K | 77.62%-116.99K | -69.65%134.37K | 40.50%187.92K | 90.73%-34.48K | -226.83%-318.13K | -1,520.74%-522.76K |
| -Change in receivables | -182.51%-139.65K | -2.00%-21.61K | -102.65%-4.62K | 193.64%169.28K | 307.44%65.83K | 58.30%-49.43K | -79.10%-21.18K | 1,032.95%174.06K | -2,972.14%-180.77K | -901.14%-31.74K |
| -Change in prepaid assets | 161.68%197.58K | -662.58%-234.79K | -235.59%-112.77K | 181.48%207.25K | -9.82%6.85K | 48.16%75.5K | 146.66%41.73K | 137.21%83.17K | -11,842.07%-254.37K | 401.35%7.59K |
| -Change in payables and accrued expense | 750.78%921.38K | -94.44%9.3K | 104.95%14.44K | -275.81%-205.71K | 61.96%-189.67K | -78.78%108.3K | -28.79%167.37K | -124.79%-291.7K | 230.99%117.01K | -1,273.64%-498.62K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -89.24%-3.48M | -27.15%-865.7K | -0.80%-456.92K | 32.91%-3.55M | 55.41%-578.08K | 34.69%-1.84M | -27.75%-680.87K | 30.06%-453.29K | -994.67%-5.3M | -1,116.76%-1.3M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,318.61%-82.11K | -521.03%-167.68K | 88.80%-40.11K | 95.81%-7.33K | 86.35%-5.79K | 73.31%-27K | 0 | -88.58%-358.06K | -133.33%-175K | |
| Net PPE purchase and sale | -2,736.74%-53.36K | -52.14%-41.08K | ---- | 88.62%-36.21K | 95.81%-7.33K | 21.30%-1.88K | 73.31%-27K | --0 | -162.00%-318.06K | -133.33%-175K |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | ---- | ---126.6K | ---- | ---3.91K | ---- | ---- | --0 | ---- | --0 | ---- |
| Net other investing changes | -635.86%-28.75K | ---- | ---- | ---- | ---- | 90.23%-3.91K | ---- | ---- | 31.60%-40K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,318.61%-82.11K | -521.03%-167.68K | ---- | 88.80%-40.11K | 95.81%-7.33K | 86.35%-5.79K | 73.31%-27K | --0 | -88.58%-358.06K | -133.33%-175K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 106,230.32%4.82M | 83.22%8.24M | 106.97%301 | 135.69%5.68M | 19,584.60%1.19M | -100.19%-4.55K | 207,212.25%4.5M | -4.32K | -52.55%2.41M | -100.17%-6.1K |
| Net issuance payments of debt | -84.14%-8.37K | -108.31%-9.22K | -55.18%-6.7K | -58.26%-17.36K | 3.23%-4.07K | -11.10%-4.55K | -65.74%-4.43K | ---4.32K | ---10.97K | ---4.21K |
| Net common stock issuance | --4.84M | 78.88%8.33M | --7K | 110.13%5.86M | --1.2M | --0 | 931,136.80%4.66M | --0 | -45.10%2.79M | --0 |
| Net other financing activities | ---4.18K | 47.59%-81.42K | ---- | 55.70%-162.91K | -299.89%-7.56K | ---- | ---155.35K | ---- | -183,776.00%-367.75K | ---1.89K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 106,230.32%4.82M | 83.22%8.24M | 106.97%301 | 135.69%5.68M | 19,584.60%1.19M | -100.19%-4.55K | 207,212.25%4.5M | ---4.32K | -52.55%2.41M | -100.17%-6.1K |
| Net cash flow | ||||||||||
| Beginning cash position | 121.88%10.01M | 287.77%2.81M | 176.25%3.26M | -73.31%1.18M | 0.08%2.66M | 45.38%4.51M | -80.64%724.07K | -73.31%1.18M | 17,065.74%4.43M | 137.30%2.66M |
| Current changes in cash | 167.94%1.26M | 90.18%7.2M | 0.21%-456.62K | 164.16%2.08M | 140.81%602.96K | -316.24%-1.85M | 695.43%3.79M | 33.45%-457.6K | -173.74%-3.25M | -144.68%-1.48M |
| End cash Position | 323.48%11.27M | 121.88%10.01M | 287.77%2.81M | 176.25%3.26M | 176.25%3.26M | 0.08%2.66M | 45.38%4.51M | -80.64%724.07K | -73.31%1.18M | -73.31%1.18M |
| Free cash from | -91.94%-3.54M | -28.10%-906.78K | -0.80%-456.92K | 36.07%-3.59M | 60.22%-585.41K | 34.68%-1.84M | -11.63%-707.87K | 34.08%-453.29K | -812.57%-5.61M | -710.50%-1.47M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.